Welcome to Homepage of:
Quality of Life Evaluation
in Dialysis Patients
SF36 Questionnaire (PDF format)
SF36
Questionnaire (MS Word/RTF format)
SF36
Questionnaire (htm format)
To obtain the score
of the questionnaires:
SF36 Software (MS Excel)
An appendix to:
Inquiries to:
J Am Soc Nephrol
12:2797-2806, 2001
© 2001 American Society of
Nephrology
Association Among SF36 Quality of Life Measures and Nutrition,
Hospitalization, and Mortality in Hemodialysis
,
,
and
* University of California, San Francisco and
Division of Nephrology San Francisco General Hospital, San Francisco,
California; University
of California, Los Angeles, Division of Nephrology Harbor-UCLA Medical Center,
Torrance, California; University
of California, Berkeley, School of Public Health, Berkeley, California.
Correspondence to Dr. Kamyar Kalantar-Zadeh, Harbor-UCLA Medical Center, Division of Nephrology and Hypertension; and UCLA, 1000 West Carson Street, Harbor Mailbox 406, Torrance, CA 90509-2910. Phone: 310-222-3891; Fax: 310-782-1837; E-mail: kkalantar@rei.edu
|
|
Abstract |
ABSTRACT. Patients on maintenance hemodialysis (MHD) often show substantial
reductions in quality of life (QoL). The SF36 (Short Form with 36
questions), a well-documented, self-administered QoL scoring system
that includes eight independent scales and two main dimensions, has
been widely used and validated. In 65 adult outpatients on MHD, the
SF36 and its scales and dimensions, scored as a number between 0 and
100, and the nutritional and inflammatory state measured by
subjective global assessment, near-infrared (NIR) body fat, body
mass index (BMI), and pertinent laboratory values, including
hemoglobin, albumin, and C-reactive protein were assessed.
Twelve-month prospective hospitalization rates and mortality were
used as the clinical outcomes. Multivariate (case-mix) adjusted
correlation coefficients were statistically significant between SF36
scores and serum albumin and hemoglobin concentrations. There were
significant inverse correlations between SF36 scores and the BMI and
NIR body fat percentage. Hypoalbuminemic, anemic, and obese patients
on MHD had a worse QoL. Prospective hospitalizations correlated
significantly with the SF36 total score and its two main dimensions
(r between -0.28 and -0.40). The Cox proportional regression
relative risk of death for each 10 unit decrease in SF36 was 2.07
(95% CI, 1.08 to 3.98; P = 0.02). Of the eight components and
two dimensions of the SF36, the Mental Health dimension and the SF36
total score had the strongest predictive value for mortality. Thus,
in patients on MHD the SF36 appears to have significant associations
with measures of nutritional status, anemia, and clinical outcomes, including
prospective hospitalization and mortality. Even though obesity,
unlike undernutrition, is not generally an indicator of poor outcome
in MHD, the SF36 may detect obese patients on MHD at higher risk for
morbidity and mortality.
Address inquiries to:
Kamyar
Kalantar-Zadeh, MD, MPH
Assistant Clinical Professor of Medicine
UCLA School of Medicine
Harbor-UCLA Medical Center
1124 W. Carson St., C-1 Annex
Torrance, CA 90502-2064
Tel: (310) 222-3891
Fax: (310) 782-1837
Email kkanatar@rei.edu
http://www.nephrology.rei.edu/kalantar.htm
Other links:
HARBOR-UCLA
DIVISION OF NEPHROLOGY AND HYPERTENSION
Harbor-UCLA
Department of Medicine
Harbor-UCLA Medical Center
Harbor-UCLA Research & Education Institute
SF36
Questionnaire (htm format)
SF36
Questionnaire (MS Word/RTF format)
SF36
Questionnaire (PDF format)
To obtain the score
of the questionnaires:
SF36 Software (MS Excel)
Inquires to: kkalantar@rei.edu